# Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness

> **NCT03480698** · — · COMPLETED · sponsor: **Ever Neuro Pharma GmbH** · enrollment: 1851 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Cerebrolysin

## Key facts

- **NCT ID:** NCT03480698
- **Lead sponsor:** Ever Neuro Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-24
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-07-15
- **Target enrollment:** 1851 (ACTUAL)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480698, "Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03480698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*